Friday, March 24, 2017 11:19:32 AM
LOS ANGELES, Calif. (May 12, 2016)
--
ViaDerma, a Los Angeles-based pharmaceutical firm has recently signed a deal with Coast to Coast Podiatry of Reseda to license its products. According to Dr. Chris Otiko, CEO of ViaDerma, the partnership will be beneficial to both companies. “ViaDerma will get our new products in front of patients who need them. And Coast to Coast will have cutting-edge medicine to help their patients in recovery,” he said. ViaDerma, Inc. produces TetraStem, a wound care drug that can also treats diabetic foot sores, acne and fight Methicillin-resistant Staphylococcus aureus (MRSA)infections.
FEATURED DaBaby and Stunna 4 Vegas's "NO DRIBBLE" Joins Music Licensing, Inc.'s Portfolio • Jun 7, 2024 10:15 AM
Mushrooms Inc. (OTC: MSRM) Announces Significant Share Buy Back by the Board Director and New Strategic Initiatives. • MSRM • Jun 5, 2024 1:32 PM
Hydromer Announces Launch of HydroThrombX Medical Device Coating Technology • HYDI • Jun 5, 2024 10:24 AM
Dr. Michael Dent Finances $1 Million to Drive HealthLynked's Healthcare Transformation • HLYK • Jun 5, 2024 8:00 AM
Avant Technologies Enters Binding LOI to Purchase Dozens of High-Performance, Immersible, AI-Powered Servers • AVAI • Jun 5, 2024 8:00 AM
IQST - iQSTEL Announces $290 Million 2024 Annual Revenue Forecast • IQST • Jun 4, 2024 1:43 PM